RE: Future time line3 Feb 2022 09:02
I am so proud of Avacta today. On both diagnostics and therapeutics, they are showing that their IP has huge, life-saving promise. However, I fear that if the pandemic has shown us anything, it is that big pharma doesn’t brook disruption. Look at Synairgen- still on the shelf while Pfizer and Merck roll out their dubious and horrendously expensive antivirals. Look at Angle’s Parsortix, still awaiting FDA approval despite numerous peer reviews showing its value.
Frankly, I don’t believe that Avacta can capitalise on this opportunity - unless they throw in their lot with a big pharma partner/patron. It’s just the way of the world. Disruption is not permitted.